0001193805-16-003486.txt : 20160621 0001193805-16-003486.hdr.sgml : 20160621 20160621164328 ACCESSION NUMBER: 0001193805-16-003486 CONFORMED SUBMISSION TYPE: F-6 POS PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160621 EFFECTIVENESS DATE: 20160621 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NeuroVive Pharmaceuticals AB/ADR CENTRAL INDEX KEY: 0001647420 IRS NUMBER: 000000000 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-6 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-205550 FILM NUMBER: 161724815 BUSINESS ADDRESS: STREET 1: MEDICON VILLAGE, SCHEELEVAGEN 2 CITY: LUND STATE: V7 ZIP: 00001 BUSINESS PHONE: 212-336-2301 MAIL ADDRESS: STREET 1: C/O PATTERSON BELKNAP C/O H. RASPE STREET 2: 1133 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Citibank,N.A./ADR CENTRAL INDEX KEY: 0001472033 IRS NUMBER: 521568099 STATE OF INCORPORATION: DC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-6 POS BUSINESS ADDRESS: STREET 1: 388 GREENWICH STREET, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 212-816-6647 MAIL ADDRESS: STREET 1: 388 GREENWICH STREET, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 F-6 POS 1 e615164_f6pos-neurovive.htm Unassociated Document
 
As filed with the Securities and Exchange Commission on June 21, 2016            
  
Registration No.  333-205550
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.   20549
                                                                                     
 
FORM F-6/A
POST-EFFECTIVE AMENDMENT NO. 1 TO
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 FOR DEPOSITARY SHARES EVIDENCED BY
AMERICAN DEPOSITARY RECEIPTS
                          
 
NEUROVIVE PHARMACEUTICAL AB
 (Exact name of issuer of deposited securities as specified in its charter)
                          
 
N/A
 (Translation of issuer's name in English)
                          
 
Kingdom of Sweden
(Jurisdiction of incorporation or organization of issuer)
                            
 
CITIBANK, N.A.
(Exact name of depositary as specified in its charter)
                            
 
399 Park Avenue
New York, New York 10043
(212) 723-5435
(Address, including zip code, and telephone number, including area code, of depositary's principal executive offices)
                                    
 
CITIBANK, N.A. – DEPOSITARY RECEIPTS DEPARTMENT
388 Greenwich Street
New York, New York 10013
(877) 248-4237
(Name, address, including zip code, and telephone number, including area code of agent for service)
                                                                    
 
Copies to:
Herman H. Raspé, Esq.
Patterson Belknap Webb & Tyler LLP
1133 Avenue of the Americas
New York, New York 10036
212-336-2000
                                                                     
 
It is proposed that this filing become effective under Rule 466:
            x  
immediately upon filing.
             o
on (Date) at (Time).
 
If a separate registration statement has been filed to register the deposited shares, check the following box:  o
 
 
 
 
 
______________________________
 
DE-REGISTERING AMERICAN DEPOSITARY SHARES
EVIDENCED BY
AMERICAN DEPOSITARY RECEIPTS
 
______________________________
 
The fifty million (50,000,000) American Depositary Shares, which were registered under Registration Statement No. 333-205550 and have not been issued prior to the date hereof, are hereby being de-registered effective immediately.
 
 
- 2 -
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post-Effective Amendment No. 1 to Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 21st day of June, 2016.
 
 
Legal entity created by the agreement set forth in the American Depositary Receipts evidencing American Depositary Shares representing shares of common stock of NeuroVive Pharmaceutical AB.
 
CITIBANK, N.A., as Depositary
  
     
       
 
By: 
/s/ Mark Gherzo
  
    Name: 
Mark Gherzo
  
    Title: Vice President  
       
 
 
- 3 -
 
 
Index of Exhibits
 
Exhibit
Document
Sequentially
Numbered Page
     
(a)
Previously Filed
  
     
(d)
Previously Filed
  
     
(e)
Rule 466 Certification
  
     

 
- 4 -
 EX-99.(E) 2 e615164_ex99-e.htm Unassociated Document
 
Exhibit (e)
 
Rule 466 Certification
 
The depositary, Citibank, N.A., represents and certifies the following:
 
 
1.
That it previously had filed a Registration Statement on Form F-6 (Registration No. 333-205550), which the U.S. Securities and Exchange Commission declared effective, with terms of deposit identical to the terms of deposit of this Post-Effective Amendment No. 1 to Registration Statement on Form F-6; and
 
 
2.
That its ability to designate the date and time of effectiveness under Rule 466 has not been suspended.
 
 
CITIBANK, N.A., as Depositary
  
       
       
 
By: 
 /s/ Mark Gherzo  
    Name: 
Mark Gherzo
  
    Title: Vice President  
       
 
Ex (e)-1